drugset / Trial / NCT00315640
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.
Timeline
- Start
- 2005-12
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Unknown | 3 mg | Other |
| Subject | Anecortave Acetate | Unknown | 15 mg | Other |
| Subject | Anecortave Acetate | Unknown | 30 mg | Other |